Autism spectrum disorder (ASD) is a genetically and phenotypically heterogeneous disorder. Efforts to identifying subtypes based on the behavioral and neural phenotypes have been unsuccessful, and the rarity of specific genetic events renders subtyping at the CNV or exonic mutation level challenging and exceedingly resource-intensive. However, exploring the impact of gene disruptions in common pathways holds promise for elucidating phenotypic subtypes and clarifying genotype-phenotype relations in ASD. Most importantly, the identification of pathway-based subtypes will advance translational goals of selecting interventions, defining treatment targets, and predicting outcomes. The current project aims to investigate the behavioral and neural phenotype, obtained through electroencephalography (EEG), in pre-identified individuals with ASD with gene mutations in the beta-catenin pathway. This project addresses the critical need to understand the pathogenesis of ASD by elucidating the relationship between ASD risk genes, brain function and behavior and the need to address the wide heterogeneity in ASD by careful subtype identification. We will include 60 participants with ASD with gene mutations in the beta-catenin pathway, 60 participants with ASD with gene disruptions falling in other pathways, and 60 participants with ASD without any identified CNVs or gene disrupting mutations along with 30 typical individuals. Given the role of beta-catenin in neuronal adhesion, synapse formation, and in the transcription of target genes linked to cell growth, differentiation, and migration, as well as preliminary evidence of behavioral disruptions in learning and memory, evidence of dysfunction of beta-catenin may be observed at both the behavioral and neurophysiological level. Electrophysiological measures will allow us to specifically address the brain systems related to learning and memory as well as those related to the core features of autism. This research holds promise for discovery of gene-brain-behavior relationships, attained through integration of genotypic, EEG, and behavioral data.

Public Health Relevance

Autism spectrum disorder (ASD) is a genetically and phenotypically heterogeneous disorder. Exploring the impact of gene disruptions in common pathways holds promise for elucidating phenotypic subtypes and clarifying genotype-phenotype relations in ASD. The identification of pathway-based subtypes will advance translational goals of selecting interventions, defining treatment targets, and predicting outcomes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH100047-04
Application #
9248447
Study Section
Child Psychopathology and Developmental Disabilities Study Section (CPDD)
Program Officer
Gilotty, Lisa
Project Start
2014-06-07
Project End
2019-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
4
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Washington
Department
Psychiatry
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Arnett, Anne B; Rhoads, Candace L; Hoekzema, Kendra et al. (2018) The autism spectrum phenotype in ADNP syndrome. Autism Res 11:1300-1310
Neuhaus, Emily; Beauchaine, Theodore P; Bernier, Raphael A et al. (2018) Child and family characteristics moderate agreement between caregiver and clinician report of autism symptoms. Autism Res 11:476-487
Hudac, Caitlin M; DesChamps, Trent D; Arnett, Anne B et al. (2018) Early enhanced processing and delayed habituation to deviance sounds in autism spectrum disorder. Brain Cogn 123:110-119
Arnett, Anne B; Cairney, Brianna E; Wallace, Arianne S et al. (2018) Comorbid symptoms of inattention, autism, and executive cognition in youth with putative genetic risk. J Child Psychol Psychiatry 59:268-276
Guo, Hui; Wang, Tianyun; Wu, Huidan et al. (2018) Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model. Mol Autism 9:64
Sanders, Stephan J; Campbell, Arthur J; Cottrell, Jeffrey R et al. (2018) Progress in Understanding and Treating SCN2A-Mediated Disorders. Trends Neurosci 41:442-456
Siper, Paige M; De Rubeis, Silvia; Trelles, Maria Del Pilar et al. (2017) Prospective investigation of FOXP1 syndrome. Mol Autism 8:57
Geisheker, Madeleine R; Heymann, Gabriel; Wang, Tianyun et al. (2017) Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains. Nat Neurosci 20:1043-1051
Hudac, Caitlin M; Stessman, Holly A F; DesChamps, Trent D et al. (2017) Exploring the heterogeneity of neural social indices for genetically distinct etiologies of autism. J Neurodev Disord 9:24
Bramswig, Nuria C; Lüdecke, H-J; Pettersson, M et al. (2017) Identification of new TRIP12 variants and detailed clinical evaluation of individuals with non-syndromic intellectual disability with or without autism. Hum Genet 136:179-192

Showing the most recent 10 out of 21 publications